A neoadjuvant dose-dense regimen was active and well tolerated in patients with muscle-invasive bladder cancer, allowing downstaging of most patients before radical cystectomy.
Original Article: Dose-Dense Chemo Shows Promise as Neoadjuvant Therapy in Bladder Cancer